Skip to main content
Filing year 2024

GLIOBLASTOMA FOUNDATION INC

Durham, North Carolina·EIN 81-2849764·NTEE H30 · Medical Research·3
Total revenue
$2.1M
Total assets
$3.7M
Total expenses
$0
Reported officers
5
Mission

THE GLIOBLASTOMA FOUNDATION IS DEDICATED TO FINDING A CURE FOR GLIOBLASTOMA BY FUNDING RESEARCH AND DRUG DEVELOPMENT, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS DEVASTATING BRAIN CANCER. THROUGH THESE INTEGRATED PROGRAMS, THE FOUNDATION ACCELERATES SCIENTIFIC DISCOVERY, EMPOWERS PATIENTS WITH INFORMATION AND RESOURCES, AND EDUCATES THE PUBLIC ABOUT THE URGENT NEED FOR BETTER TREATMENTS AND IMPROVED OUTCOMES.

Executive compensation, broken down

Form 990 · Schedule J · 1 reported individual · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation

Plus 4 unpaid individuals.

Browse compensation in Medical Research

Up 2%
from 2023

From $336k in 2023 to $343k in 2024.

$336k
2023
$343k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.